816.298.8708
Call Today For A Free Consultation
Antidepressants & Anti-Seizure medications such as Topamax, Depakote, Zoloft, Paxil, Celexa, Lexapro, and others, have been associated with a higher risk of Birth Defects if taken during pregnancy. These drugs have been linked to birth defects such ...
New developments in a case against Pfizer Inc. show that the company may have known about the potential link between the popular anti-depressant Zoloft and birth defects. If your child was born with birth defects after the mother took Zoloft during ...
Recently, federal safety regulators approved the sale of a new alcohol product sold under the brand name Palcohol. Palcohol is a liquor condensed into powder and easily mixed with liquids to create a cocktail. The product will be easy to transport ...
There are few things more concerning than being prescribed medication that is supposed to help you and learning that you may be at risk for devastating side effects. That is the situation that thousands of Benicar users find themselves in. Benicar , ...
An orofacial cleft occurs when parts of the lip or palate do not completely fuse together during the first 3 months of pregnancy. A cleft lip may appear as a small notch in the edge of the lip only or extend into the nose. It may also extend into the ...
Avandia Recall: In Sept. 2010, the U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other ...
Recently, the FDA issued a warning about the epilepsy and migraine drug, Topamax, that if taken during pregnancy could increase risk of birth defects. Depakote, a popular anti-epileptic used to treat seizures, also increases the risk of devastating ...
Darvocet has been removed from the U.S. Market because of its association with serious heart episodes including heart attack, heart rhythm problems and death. Darvocet has been a cause for concern for years, but it was only removed from the market in ...
The following excerpt is from the FDA concerning Dilantin. Source: fda.gov Dilantin-125 (phenytoin oral suspension, USP) Suspension Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- April 2009 ...